TOBRADEX ong opht tb 3.5 g

7680507670192 CH-50767 S01CA01 11.06.1.
TOBRADEX ong opht tb 3.5 g
TOBRADEX ong opht tb 3.5 g
TOBRADEX ong opht tb 3.5 g
1 / 3
google

Details

Product number
5076701
CPT
-
Packaging group
3.5
Unit
g
Composition
dexamethasonum 1 mg, tobramycinum 3 mg, paraffinum liquidum, vaselinum album, chlorobutanolum, ad unguentum pro 1 g.

Articles (1)

Tobradex, Augensalbe
Augensalbe
3.5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
20/04/2020
Patient information leaflet
Français
20/04/2020
Patient information leaflet
Italien
20/04/2020

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
3.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)

Reimbursement information

Public price
CHF 14.40
Specialties list
Yes
Generic
No
SL addition date: 15/03/1995

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
50767
Drug name
Tobradex, Augensalbe
Galenic form
AUGS
ATC Code
S01CA01
Authorization status
Z
Dispensation category
A
First authorization
15/04/1994
Authorization expiration date
31/12/9999
IT number
11.06.1.
Domain
Human medicine
Field of application
Bakterielle Augeninfektionen

Packaging details

Description (FR)
TOBRADEX ong opht tb 3.5 g
Description (DE)
TOBRADEX Augensalbe Tb 3.5 g
Market launch
15/04/1994
Narcotic (BTM)
No